BiTE Antibodies Market with COVID-19 Impact Analysis, By Type (Blinatumab, Catumaxomab, Duligotumab), By Application (Infectious Diseases, Viral Infections, Signaling Pathways, Bacterial Infections, Cancer Diagnostics, Gene Therapy, Tumor Angiogenesis, Others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
BiTE Antibodies Market size was valued at USD 620.4 Million in 2022, expanding at a CAGR of 8.2% from 2023 to 2030.
BiTE antibodies, also known as bispecific T-cell engagers, are a type of immunotherapy designed to enhance the body's immune response against cancer cells. They are a class of bispecific antibodies that concurrently bind to both cancer cells and T cells, which are a type of immune cell involved in recognizing and destroying abnormal cells. The modular nature of BiTE technology facilitates the generation of molecules against tumor-specific antigens, allowing off-the-shelf immune monotherapy. Advances in immuno-oncology made with BiTE technology could substantially improve the treatment of hematologic and solid tumors and offer enhanced activity in combination with other treatments.
BiTE Antibodies Market- Market Dynamics
The rising global burden of cancer and the unavailability of effective curing drugs possess are expected to propel the growth of the BiTE Antibodies Market.
Cancer is a significant global health challenge, and its burden continues to rise. While advances have been made in cancer treatment and management, the unavailability of effective curative drugs remains a concern. One promising approach to cancer immunotherapy is the use of BiTE (bispecific T-cell engager) antibodies. According to the world health organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. BiTEs provide the advantage of the flexibility of targeting multiple antigens simultaneously and sequentially and can be used in combination with chemotherapy, small molecules, and immunomodulatory drugs, such as checkpoint inhibitors. Overall, the rising global burden of cancer and the unavailability of effective curing drugs possess are expected to propel the growth of the BiTE Antibodies Market.
BiTE Antibodies Market- Key Insights
- As per the analysis shared by our research analyst, the global BiTE Antibodies market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2023-2030)
- The BiTE Antibodies industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- On the basis of region, North America was the leading revenue generator in 2022
BiTE Antibodies Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America dominates the BiTE Antibodies market due to the highest numbers of several cancers such as lung cancer, prostate cancer, breast cancer, and cervical cancer. National cancer institute predicted that in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. Furthermore, Europe and Asia Pacific are projected to demand for BiTE Antibodies Market, due to the growing demand for targeted and personalized therapies and the emergence of novel bispecific antibody formats and technologies.
BiTE Antibodies Market- Competitive Landscape:
As more research supports the benefits of BiTE antibodies, there is a growing interest in developing and utilizing these therapies for various types of cancer. Several pharmaceutical companies and biotechnology firms are investing in research and development to create their own BiTE antibody candidates. This has led to an increase in the number of companies competing to bring effective BiTE antibody therapies to the market.
The pharmaceutical industry is increasingly focused on the development of next-generation drug products that allow the targeted delivery of active ingredients with multiple functionalities, increasing both efficacy and safety. Bi- and multispecific antibodies are prime examples of new drug substances with the potential to offer higher potency combined with new mechanisms of action while also reducing the cost and time for drug development.
Companies are striving to differentiate their products by optimizing the design of BiTE antibodies, improving manufacturing processes, and exploring combination therapies to enhance their effectiveness.
Recent Developments:
- In October 2022, Reckitt and Mondi announced the launch of a new packaging made of paper which is made of 75% less plastic and will be used for packaging Finish dishwater tablets. The move is expected to eliminate the use of almost 2,000 tonnes of plastic annually once it is completely in action
Key features of the study:
- This proposed research study on BiTE Antibodies market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the BiTE Antibodies market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for BiTE Antibodies market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the BiTE Antibodies market
- Impact of COVID-19 on BiTE Antibodies market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on BiTE Antibodies market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the BiTE Antibodies market, we have also included competitive landscape and key innovator analysis for the BiTE Antibodies market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the BiTE Antibodies market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global BiTE Antibodies market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BITE ANTIBODIES MARKET KEY PLAYERS
- ImmunGene, Inc.
- Celgene
- Amgen Inc.
- Immunocore Limited
- Oncomed Pharmaceuticals
- Abbvie
- Novartis AG
- Pfizer Inc.
- Merck & Co., Inc.
- Paktis Antibody Services GmBH
- Ganymed Pharmaceuticals
- Dow Pharmaceutical Solutions
- Hoffmann-La Roche AG
- Bayer AG
- Janseen Biotech
- Fabion Pharmaceuticals
- Others
GLOBAL BITE ANTIBODIES MARKET, BY TYPE
- Blinatumab
- Catumaxomab
- Duligotumab
GLOBAL BITE ANTIBODIES MARKET, BY APPLICATION
- Infectious Diseases
- Viral Infections
- Signaling Pathways
- Bacterial Infections
- Cancer Diagnostics
- Gene Therapy
- Tumor Angiogenesis
- Others
GLOBAL BITE ANTIBODIES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. BiTE Antibodies Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. BiTE Antibodies Market Snippet by Type
2.1.2. BiTE Antibodies Market Snippet by Application
2.1.3. BiTE Antibodies Market Snippet by Country
2.1.4. BiTE Antibodies Market Snippet by Region
2.2. Competitive Insights
3. BiTE Antibodies Key Market Trends
3.1. BiTE Antibodies Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. BiTE Antibodies Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. BiTE Antibodies Market Opportunities
3.4. BiTE Antibodies Market Future Trends
4. BiTE Antibodies Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. BiTE Antibodies Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. BiTE Antibodies Market Landscape
6.1. BiTE Antibodies Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. BiTE Antibodies Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. Blinatumab
7.1.3. Catumaxomab
7.1.4. Duligotumab
7.1.5. Others
8. BiTE Antibodies Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Infectious Diseases
8.1.3. Viral Infections
8.1.4. Signaling Pathways
8.1.5. Bacterial Infections
8.1.6. Cancer Diagnostics
8.1.7. Gene Therapy
8.1.8. Tumor Angiogenesis
8.1.9. Others
9. BiTE Antibodies Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. BiTE Antibodies Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. BiTE Antibodies Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. BiTE Antibodies Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. BiTE Antibodies Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. BiTE Antibodies Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- BiTE Antibodies Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. ImmunGene, Inc.
10.2.2. Celgene
10.2.3. Amgen Inc.
10.2.4. Immunocore Limited
10.2.5. Oncomed Pharmaceuticals
10.2.6. Abbvie
10.2.7. Novartis AG
10.2.8. Pfizer Inc.
10.2.9. Merck & Co., Inc.
10.2.10. Paktis Antibody Services GmBH
10.2.11. Ganymed Pharmaceuticals
10.2.12. Dow Pharmaceutical Solutions
10.2.13. F. Hoffmann-La Roche AG
10.2.14. Bayer AG
10.2.15. Janseen Biotech
10.2.16. Fabion Pharmaceuticals
10.2.17. Others
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
